Dorsey & Whitney Trust CO LLC Buys 201 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Dorsey & Whitney Trust CO LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,931 shares of the medical equipment provider’s stock after acquiring an additional 201 shares during the quarter. Dorsey & Whitney Trust CO LLC’s holdings in Intuitive Surgical were worth $2,574,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Fairfield Financial Advisors LTD increased its stake in Intuitive Surgical by 50.2% during the 4th quarter. Fairfield Financial Advisors LTD now owns 4,921 shares of the medical equipment provider’s stock valued at $2,569,000 after purchasing an additional 1,645 shares in the last quarter. Naviter Wealth LLC increased its stake in Intuitive Surgical by 616.1% during the 4th quarter. Naviter Wealth LLC now owns 3,595 shares of the medical equipment provider’s stock valued at $1,876,000 after purchasing an additional 3,093 shares in the last quarter. Lifeworks Advisors LLC bought a new stake in Intuitive Surgical during the 4th quarter valued at $222,000. Larson Financial Group LLC increased its stake in Intuitive Surgical by 379.7% during the 4th quarter. Larson Financial Group LLC now owns 4,097 shares of the medical equipment provider’s stock valued at $2,139,000 after purchasing an additional 3,243 shares in the last quarter. Finally, AMF Tjanstepension AB bought a new stake in Intuitive Surgical during the 4th quarter valued at $2,873,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 489 shares of the company’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $533.18, for a total transaction of $260,725.02. Following the sale, the senior vice president now directly owns 2,091 shares of the company’s stock, valued at $1,114,879.38. This represents a 18.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,579 shares of company stock valued at $7,756,844 over the last three months. 0.90% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages have commented on ISRG. Evercore ISI boosted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Barclays upped their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Truist Financial upped their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Wells Fargo & Company upped their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Stock Down 3.8 %

NASDAQ ISRG opened at $518.26 on Friday. The company has a market cap of $184.59 billion, a PE ratio of 80.85, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm’s 50-day simple moving average is $571.36 and its two-hundred day simple moving average is $531.53.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.